CureVac NV (CVAC)
4.66
0.00 (0.00%)
USD |
NASDAQ |
Feb 06, 16:00
CureVac SG&A Expense (TTM) : 68.15M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| BioNTech SE | 597.23M |
| Immatics NV | 56.43M |
| Bayer AG | 16.53B |
| MediGene AG | -- |
| InflaRx NV | 21.12M |